4559:TYO
Zeria Pharmaceutical Co Ltd
¥1,925.00
arrow_downward
-0.21%(-4.00) 1D
Okt 9, 3:30:00 PM GMT+9 · JPY
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 4559...
Buksan
¥1,923
Mataas
¥1,940
Mababa
¥1,919
Mkt. cap
96.48B
Avg. na dami
170.22K
Dami
77.50K
Dividend
2.55%
Bawat tatlong buwang dividend
¥12
Petsa ng ex-dividend
Set 29, 2026
P/E ratio
10.31
Mataas nang 52-wk
¥2,434
Mababa nang 52-wk
¥1,878
EPS
¥187
Mga natitirang share
50.11M
Bilang ng mga empleyado
2K
Buksan
¥1,923
Mataas
¥1,940
Mababa
¥1,919
Mkt. cap
96.48B
Avg. na dami
170.22K
Dami
77.50K
Dividend
2.55%
Bawat tatlong buwang dividend
¥12
Petsa ng ex-dividend
Set 29, 2026
P/E ratio
10.31
Mataas nang 52-wk
¥2,434
Mababa nang 52-wk
¥1,878
EPS
¥187
Mga natitirang share
50.11M
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Bloomberg.com
·
3 oras ang nakalipas
Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap
The Washington Post
·
5 araw ang nakalipas
Stocks hit record high even as consumers feel dreary
The Motley Fool
·
1 buwan ang nakalipas
Billionaire Israel Englander's 2 Biggest Bets Are on the S&P 500, and He Just Bought More
Investor's Business Daily
·
1 buwan ang nakalipas
Dow Jones Futures Fall; Nvidia, Tariffs, Warsh In Focus
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
Tungkol sa Zeria Pharmaceutical Co Ltd